COLISTIMETHATE SODIUM 1MILLIONI.U. IP

A bactericidal antibiotic for the treatment of life-threatening infections due to multidrug-resistant gram-negative bacteria. (Vicente Pintado, 2008) An effective and safe antimicrobial agent for multidrug-resistant Gram-negative bacterial infections. (Argyris S Michalopoulos, 2010) Possesses excellent bactericidal activity against most gram-negative bacilli. (Gurjar, 2015) A potential antimicrobial agent against Gram-negative bacteria, particularly those strains which are resistant to more commonly used antibiotics. (C R Catchpole, 1997) Active against almost all strains of Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter, and Enterobacter species. (Nikolaos Markou, 2003) A potent alternative drug to imipenem for the management of ventilator-associated pneumonia due to carbapenem-resistant strains of Acinetobacter baumannii. (J Garnacho-Montero, 2003) A very reliable alternative for the management of life-threatening nosocomial infections due to multidrug-resistant gram-negative bacteria. (Falagas, 2011) The last-line defense against human infections caused by multidrug-resistant Gram-negative organisms such as carbapenemase-producer Enterobacterales, Acinetobacter baumanni, and Pseudomonas aeruginosa. (Ferdinando F. Andrade, 2020) An efficient antimicrobial agent against nosocomial infections, including bacteremia, ventilator-associated pneumonia, urinary tract infection, and meningitis. (Falagas, 2011) A last-line therapeutic option to combat severe infections of multidrug-resistant Gram-negative bacteria. (Pornpan Koomanachai C. B., 2014)